Neoplasm Metastasis Clinical Trials

315 clinical trials for Neoplasm Metastasis across international registries, including 15 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan — RECRUITING
• A Study of LY4257496 in Participants With Cancer (OMNIRAY) — RECRUITING · PHASE1
• A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) — RECRUITING · PHASE3
• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — RECRUITING · PHASE3
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — RECRUITING · PHASE3
• A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract — RECRUITING · PHASE3
• A Study of LY4175408 in Participants With Advanced Cancer — RECRUITING · PHASE1
• FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3 — RECRUITING · PHASE1
• A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC — RECRUITING · PHASE3
• Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases — RECRUITING · NA
• Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma — RECRUITING · PHASE2
• Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC — RECRUITING · PHASE1
• Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. — RECRUITING · NA
• Bone Metastases Database of Patients Treated Surgically for Impending or Pathologic Fracture of Long Bones — RECRUITING
• EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers — RECRUITING · PHASE1
• A Study of Olaratumab Alone and in Combination With Standard Chemotherapy in Children With Cancer — OTHER · PHASE1
• Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer — NOT_YET_RECRUITING · PHASE2
• Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) — ACTIVE_NOT_RECRUITING · PHASE1
• Pluvicto Real-world Investigation in Survival in Metastatic CRPC — NOT_YET_RECRUITING
• A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer — COMPLETED · PHASE1
• A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) — ACTIVE_NOT_RECRUITING · PHASE3
• Expanded Access for Vepugratinib (LY3866288) in Participants With Fibroblast Growth Factor Receptor 3 (FGFR3) Altered Solid Tumors — OTHER
• Inhaled mRNA Immunotherapy for Patients With Advanced Lung Cancer or Pulmonary Metastatic Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Cognitive Outcome After SRS or WBRT in Patients With Multiple Brain Metastases (CAR-Study B) — COMPLETED · NA
• Study of PF-07265807 in Participants With Metastatic Solid Tumors. — TERMINATED · PHASE1
• CIRSE Registry for LifePearl Microspheres — COMPLETED
• CIRSE Emprint Microwave Ablation Registry — COMPLETED
• Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid Tumors — COMPLETED · NA
• CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma — ACTIVE_NOT_RECRUITING · PHASE2
• 9-ING-41 in Patients With Advanced Cancers — ACTIVE_NOT_RECRUITING · PHASE2
• Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer — COMPLETED · PHASE2
• SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases — TERMINATED · NA
• Do Patients Want to Engage in Discussions Dedicated to Anticipating (DDA) Their Preferences of Care in the Event of Worsening Health Status? — COMPLETED
• Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases — ACTIVE_NOT_RECRUITING · NA
• Proof-of-concept Study of Blood Markers of Tumor Dissemination in Patients With Versus Without Intestinal Polyps — COMPLETED
• Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver Cancer — COMPLETED
• Platform Trial Evaluating Safety and Efficacy of Ezabenlimab Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours — COMPLETED · PHASE2
• Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors — COMPLETED · PHASE1
• A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors (MK-6837-001) — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of LY3039478 in Participants With Advanced Cancer — COMPLETED · PHASE1
• A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies — ACTIVE_NOT_RECRUITING · PHASE2
• Hepatic Resection for Metastatic Pancreatic Cancer — ACTIVE_NOT_RECRUITING
• Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2) — COMPLETED · NA
• PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy — COMPLETED · PHASE1
• Whole Brain Radiation Using IMRT for Patients With Brain Metastases — COMPLETED · NA
• A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01) — WITHDRAWN · PHASE1
• Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) — COMPLETED · NA
• Facilitating Communication Study — COMPLETED · NA

Refine this search